北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 药剂科  > 期刊论文
学科主题: 药剂学
题名:
血小板膜糖蛋白Ⅱb/Ⅲa受体拮抗剂的研究进展
其他题名: Research Progress of Platelet GlycoproteinⅡb/Ⅲa Acceptor Antagonist
作者: 王颖峥; 周颖; 崔一民
关键词: 血小板糖蛋白 ; (GP)Ⅱb/Ⅲa受体拮抗剂 ; 血小板减少症 ; Platelet Glycoprotein ; GP IIb/IIIa Acceptor Antagonist ; Thrombocytopenia
刊名: 药品评价
发表日期: 2013
DOI: 10.3969/j.issn.1672-2809.2013.18.008
期: 18, 页:31-33,36
文章类型: Journal Article
摘要: 血小板糖蛋白(G P)Ⅱb/Ⅲa受体是血小板聚集血栓形成的最终共同途径,(G P)Ⅱb/Ⅲa受体拮抗剂通过与受体结合抑制血小板凝集,从而抑制血栓形成,是一类高效和特异的抗血小板药物,越来越广泛地应用于择期经皮冠状动脉介入治疗(P C I)、非ST段抬高的急性冠脉综合征(NSTE-ACS)、ST段抬高心肌梗死(STEMI)等疾病。 Platelet glycoprotein(GP)Ⅱb/Ⅲa receptor is the final common pathway of platelet aggregation in thrombus formation. GPⅡb/Ⅲa receptor antagonist inhibits platelet aggregation by binding to the receptor and inhibits thrombosis, which is efficient and specific. GPⅡb/Ⅲa receptor antagonist is more and more widely used in elective percutaneous coronary intervention (PCI), non-ST-segment elevation acute coronary syndrome (NSTE-ACS), ST segment elevation myocardial infarction (STEMI) and other diseases.
语种: 中文
原文出处: 查看原文
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/43909
Appears in Collections:北京大学第一临床医学院_药剂科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 北京大学第一医院药剂科,北京,100034

Recommended Citation:
王颖峥,周颖,崔一民. 血小板膜糖蛋白Ⅱb/Ⅲa受体拮抗剂的研究进展[J]. 药品评价,2013(18):31-33,36.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[王颖峥]'s Articles
[周颖]'s Articles
[崔一民]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[王颖峥]‘s Articles
[周颖]‘s Articles
[崔一民]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace